Ashland’s $1.18 Billion of Credit Facilities

Cravath represented the borrower, Ashland LLC, in connection with the arrangement of its $250 million three‑year term loan A facility, $250 million five‑year term loan A facility and $680 million five‑year revolving credit facility provided by The Bank of Nova Scotia, to be used to finance the acquisition of Pharmachem Laboratories, Inc. and repay existing indebtedness. Ashland LLC is an indirect subsidiary of Ashland Global Holdings Inc., a leading provider of specialty chemical solutions. The transaction closed on May 17, 2017.

The Cravath team included partner George E. Zobitz, senior attorney Christopher J. Kelly and associates Steven Y. Li and Adam M. Sanchez on banking matters and senior attorney Annmarie M. Terraciano on environmental matters. Philip F. Schreiber also worked on executive compensation and benefits matters.